I am a postdoctoral researcher at the MRC Centre for Global Infectious Disease Analysis, based at the Department of Infectious Disease Epidemiology.
My research is focussed on the transmission, prevention and alleviation of infectious disease. I use a combination of mathematical, statistical and computational models to study a variety of viruses, including dengue, Middle Eastern Respiratory Syndrome (MERS), and in recent years COVID-19. Since the pandemic, I have been especially interested in pandemic preparedness and emerging threats to human health.
I previously worked at the Department for Immunology, studying the within-host dynamics and viral persistence of Human T-Lymphotropic Virus type-1 (HTLV-1), where I also worked on novel approaches to estimate immunological and microbiological diversity.
My background is in pure mathematics and computational biology. I am interested in spatiotemporal modelling, individual-based modelling and more generally stochastic modelling, as well as Bayesian statistics and the analysis of clinical trial data. Where possible, I like my work to have practical implications for policy, for example in the deployment of vaccines or other interventions for infection control.
et al., 2022, Prophylactic and reactive vaccination strategies for healthcare workers against MERS-CoV
et al., 2021, Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England, Science Translational Medicine, Vol:13, ISSN:1946-6234, Pages:1-12
et al., 2021, Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level Phase III data, Elife, Vol:10, ISSN:2050-084X
et al., 2021, Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England, Nature, Vol:593, ISSN:0028-0836, Pages:266-269
et al., 2021, Modelling the impact of the Tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns, Bmj Open, Vol:11, ISSN:2044-6055
et al., 2020, The relative contributions of infectious and mitotic spread to HTLV-1 persistence, PLOS Computational Biology, Vol:16, ISSN:1553-734X
et al., 2020, Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand